Tag Archives: ASCO

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exosome Diagnostics, Inc., the world’s only provider of a revolutionary liquid biopsy platform that enables analysis of both living and dying processes of disease states, thus aiming to reduce or eliminate the need for tissue biopsies, today announced ...

from Drug Discovery & Development by Ryan Bushey The annual American Society of Clinical Oncology (ASCO) meeting started Saturday in Chicago with news that there could be a viable alternative to tissue biopsies coming down the pipeline. Guardant Health, a ...

Prostate cancer (PCa) is the second leading cause of cancer death among men in the United States, with an anticipated 233,000 new cases and nearly 29,480 deaths in 2014. The definitive diagnostic for PCa is the prostate needle biopsy, typically ...